Merger Termination Windfall: Rallybio recently secured a $50 million termination fee following the end of a proposed merger, bolstering its cash reserves and extending operational runway well past 12 months. This development has drawn attention in financial circles for its potential to stabilize the biotech firm's near-term outlook.
Notable Insider Purchases: A prominent 10% stakeholder executed multiple open-market acquisitions totaling over $4 million in the days after the fee receipt, with the latest tranche exceeding $1.1 million at prices near $14. Observers on social media highlight these moves as clear signals of confidence amid the enhanced liquidity.
Market Sentiment Shift: Broader discussions emphasize how the cash influx could support ongoing development programs without immediate dilution concerns. The pattern of repeated buying by the same investor has fueled speculation about future strategic flexibility.
Note: This discussion summary was generated from an AI condensation of post data.
Rallybio Insider Trading Activity
Rallybio insiders have traded $RLYB stock on the open market 12 times in the past 6 months. Of those trades, 11 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $RLYB stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, LLC ADAR1 has made 11 purchases buying 286,264 shares for an estimated $4,002,700 and 0 sales.
- JONATHAN I LIEBER (Chief Financial Officer) sold 789 shares for an estimated $3,992
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Rallybio Hedge Fund Activity
We have seen 18 institutional investors add shares of Rallybio stock to their portfolio, and 35 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 581,652 shares (+274.6%) to their portfolio in Q1 2026, for an estimated $5,217,418
- CORMORANT ASSET MANAGEMENT, LP added 400,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $3,588,000
- BALYASNY ASSET MANAGEMENT L.P. added 376,573 shares (+inf%) to their portfolio in Q1 2026, for an estimated $3,377,859
- LAURION CAPITAL MANAGEMENT LP added 302,756 shares (+inf%) to their portfolio in Q1 2026, for an estimated $2,715,721
- JOHNSON & JOHNSON removed 301,644 shares (-66.4%) from their portfolio in Q1 2026, for an estimated $2,705,746
- NANTAHALA CAPITAL MANAGEMENT, LLC added 300,635 shares (+inf%) to their portfolio in Q1 2026, for an estimated $2,696,695
- 5AM VENTURE MANAGEMENT, LLC removed 162,053 shares (-35.7%) from their portfolio in Q1 2026, for an estimated $1,453,615
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
